Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
27 févr. 2024 09h00 HE
|
Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
Neuromodulation Market is Expected to Reach $11.0 Billion | MarketsandMarkets™
22 févr. 2024 07h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Neuromodulation market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR...
Neuromodulation Devices Market Report 2024-2034: Surging Demand for Deep Brain Stimulation (DBS) in Neuromodulation
12 févr. 2024 04h37 HE
|
Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.Revenue for the neuromodulation devices market is...
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
30 janv. 2024 09h18 HE
|
Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
18 janv. 2024 08h00 HE
|
Curonix LLC
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
Global Neuromodulation Devices Markets, 2021-2027 with 2023 as the Base Year - Future Growth Potential Enhanced by Expanding Clinical Indications and Technological Advancements
13 oct. 2023 06h13 HE
|
Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Devices Market, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.This research service analyzes the...
Global Neuromodulation Strategic Research Report 2023: Market to Reach $11.6 Billion by 2030 - Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
29 sept. 2023 04h13 HE
|
Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Neuromodulation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Neuromodulation Market to Reach...
Neuromodulation Market is estimated to be US$ 12.23 billion by 2030 with a CAGR of 8.9% during the forecast period – By PMI
28 sept. 2023 13h00 HE
|
PMI
Covina, Sept. 28, 2023 (GLOBE NEWSWIRE) -- What is Neuromodulation? Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of...
Synapse Dental Completes Equity Financing Round with Backing From AAO Innovation & Transformation Fund
22 sept. 2023 08h00 HE
|
Synapse Dental
CRANSTON, R.I., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Synapse Dental, the maker of the Dental Pain EraserTM, announced the completion of its first outside equity financing with backing from the...
STIMVIA Unveils Innovative Solution to Transform CNS Disorder Treatments at TechCrunch Disrupt 2023
20 sept. 2023 12h00 HE
|
STIMVIA s.r.o.
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- STIMVIA, a pioneer medical technology company, introduces an effective non-invasive neuromodulation treatment, URIS®, addressing deep brain...